KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
301263 Guangdong Taienkang Pharmaceutical
- 15.43
- -0.28-1.78%
Market Closed Dec 13 15:00 CST
6.57BMarket Cap48.68P/E (TTM)
15.80High15.41Low51.33KlotVolume15.66Open15.71Pre Close80.17MTurnover1.95%Turnover Ratio40.93P/E (Static)425.50MShares17.4352wk High3.70P/B4.06BFloat Cap11.3552wk Low18.85Limit Up262.97MShs Float23.69Historical High12.57Limit Down2.48%Amplitude10.91Historical Low0.30Dividend TTM15.62Avg Price28.61KlotAsk1.94%Div YieldTTM100Lot Size21.97KlotBid
Guangdong Taienkang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -9.42%487.57M | -9.60%335.05M | -28.65%129.49M | -3.23%727.82M | -0.09%538.27M | 10.69%370.65M | 12.07%181.49M | 22.27%752.13M | 23.72%538.76M | 14.15%334.87M |
| Refunds of taxes and levies | -23.77%184K | -24.61%175.67K | -24.49%153.43K | -86.61%248.52K | -86.66%241.39K | -79.41%233.02K | --203.18K | -60.88%1.86M | -58.38%1.81M | -73.57%1.13M |
| Cash received relating to other operating activities | -33.31%9.44M | -41.82%6.2M | 24.80%7.31M | -18.55%16.49M | -53.62%14.15M | -10.73%10.66M | 1.41%5.86M | 67.25%20.24M | 184.99%30.51M | 18.25%11.94M |
| Cash inflows from operating activities | -10.04%497.19M | -10.51%341.43M | -26.98%136.95M | -3.83%744.56M | -3.23%552.66M | 9.66%381.55M | 11.83%187.56M | 22.50%774.23M | 26.76%571.08M | 13.07%347.94M |
| Goods services cash paid | 1.18%223.02M | 9.84%142.16M | 22.28%73.28M | -11.27%276.14M | -0.58%220.42M | -12.97%129.42M | -1.59%59.92M | 11.44%311.23M | 5.71%221.71M | 15.24%148.71M |
| Staff behalf paid | 4.06%90.86M | -0.24%59.7M | -3.36%30.84M | 1.29%114.11M | 5.69%87.32M | 10.59%59.84M | 16.60%31.91M | 18.06%112.66M | 13.31%82.61M | 10.09%54.11M |
| All taxes paid | -11.74%85.61M | -18.71%64.78M | 28.51%29.27M | 99.15%114.35M | 118.21%97M | 134.84%79.7M | 116.56%22.78M | -10.83%57.42M | -14.86%44.45M | -5.79%33.94M |
| Cash paid relating to other operating activities | 15.90%112.65M | 12.91%70.72M | 26.02%36.81M | 1.61%146.43M | -22.40%97.2M | -6.66%62.63M | 20.74%29.21M | 97.71%144.11M | 113.26%125.25M | 63.09%67.1M |
| Cash outflows from operating activities | 2.03%512.14M | 1.74%337.35M | 18.34%170.2M | 4.10%651.03M | 5.89%501.93M | 9.13%331.59M | 16.96%143.82M | 22.15%625.42M | 20.44%474.03M | 18.99%303.85M |
| Net cash flows from operating activities | -129.46%-14.94M | -91.83%4.08M | -176.00%-33.24M | -37.15%93.53M | -47.73%50.73M | 13.30%49.96M | -2.27%43.73M | 23.99%148.81M | 70.49%97.05M | -15.81%44.09M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -54.81%472M | -67.10%332M | -89.18%46M | 48.61%1.29B | 242.46%1.04B | --1.01B | --425M | 1,366.10%865M | 1,694.12%305M | ---- |
| Cash received from returns on investments | -30.68%3.9M | -48.26%3.03M | -67.87%525.92K | -8.23%8.55M | 185.49%5.62M | --5.86M | --1.64M | 3,410.43%9.32M | 2,016.84%1.97M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -92.53%6.4K | -92.50%6.4K | -64.54%5.81K | 1,482.31%85.67K | 1,482.31%85.67K | 4,643.67%85.39K | 3,177.20%16.39K | -94.32%5.41K | -93.26%5.41K | -97.76%1.8K |
| Cash received relating to other investing activities | --1.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -54.56%477.18M | -66.99%335.04M | -89.09%46.53M | 48.02%1.29B | 242.12%1.05B | 56,385,985.09%1.01B | 85,330,498.40%426.65M | 1,372.90%874.33M | 1,687.51%306.98M | -97.76%1.8K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -29.54%54.55M | 2.01%52.49M | 31.51%33.51M | 122.53%200.01M | 8.36%77.42M | 56.91%51.45M | 103.92%25.48M | 101.31%89.88M | 122.49%71.44M | 122.85%32.79M |
| Cash paid to acquire investments | -68.36%340.33M | -77.69%221M | -91.78%46M | 13.98%1.3B | 14.73%1.08B | 58.48%990.5M | --559.5M | 1,827.89%1.14B | 3,726.34%937.45M | --625M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --188.56M | --138.56M | --138.56M | --138.56M | ---- | ---- | ---- |
| Cash outflows from investing activities | -69.42%394.88M | -76.83%273.49M | -89.01%79.51M | 37.29%1.69B | 28.01%1.29B | 79.47%1.18B | 5,691.07%723.54M | 1,084.14%1.23B | 1,682.18%1.01B | 4,370.48%657.79M |
| Net cash flows from investing activities | 134.11%82.3M | 137.18%61.56M | 88.89%-32.97M | -10.74%-390.93M | 65.63%-241.27M | 74.83%-165.56M | -2,276.30%-296.88M | -697.09%-353.01M | -1,679.86%-701.92M | -4,395.00%-657.79M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.08B | --1.08B | --1.08B |
| Cash from borrowing | 133.84%157M | 607.01%153M | 510.00%61M | 768.20%173.64M | 235.70%67.14M | 8.20%21.64M | 0.00%10M | -81.40%20M | -76.88%20M | -73.86%20M |
| Cash inflows from financing activities | 133.84%157M | 607.01%153M | 510.00%61M | -84.18%173.64M | -93.88%67.14M | -98.03%21.64M | -99.08%10M | 921.19%1.1B | 1,169.09%1.1B | 1,335.12%1.1B |
| Borrowing repayment | 283.20%76.64M | 108.20%41.64M | 155.00%25.5M | -81.73%20M | -79.69%20M | -74.36%20M | -50.00%10M | -13.32%109.48M | -10.72%98.48M | -22.24%78M |
| Dividend interest payment | -20.51%132.04M | -15.18%130.25M | 728.81%1.51M | 94.36%166.78M | 94.13%166.11M | 80.96%153.56M | -76.94%182.31K | 1,908.30%85.81M | 2,431.51%85.57M | 3,383.71%84.86M |
| Cash payments relating to other financing activities | 20.96%1.38M | 21.37%874.19K | 46.90%490.3K | 39.22%40.55M | -94.51%1.14M | -95.63%720.27K | -94.69%333.78K | 243.56%29.13M | 1,136.93%20.75M | 1,236.20%16.46M |
| Cash outflows from financing activities | 12.18%210.06M | -0.87%172.76M | 161.52%27.5M | 1.30%227.33M | -8.57%187.25M | -2.81%174.28M | -61.17%10.52M | 61.39%224.42M | 77.53%204.8M | 72.48%179.32M |
| Net cash flows from financing activities | 55.82%-53.06M | 87.05%-19.76M | 6,590.96%33.5M | -106.15%-53.69M | -113.45%-120.11M | -116.62%-152.64M | -100.05%-516.08K | 2,868.98%873.44M | 3,195.55%893.06M | 3,444.02%918.54M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -82.42%4.79K | -101.91%-675.29 | -93.45%-4.34K | 38.96%-48.61K | 272.25%27.25K | 3,393.88%35.39K | 89.58%-2.25K | -4.28%-79.63K | 111.08%7.32K | 101.97%1.01K |
| Net increase in cash and cash equivalents | 104.60%14.3M | 117.10%45.87M | 87.10%-32.72M | -152.47%-351.14M | -207.78%-310.63M | -187.98%-268.2M | -123.21%-253.67M | 1,416.83%669.17M | 2,622.67%288.2M | 2,882.66%304.84M |
| Add:Begin period cash and cash equivalents | -43.53%455.59M | -43.53%455.59M | -43.53%455.59M | 486.42%806.74M | 486.42%806.74M | 486.42%806.74M | 491.06%806.74M | 47.21%137.57M | 47.21%137.57M | 47.21%137.57M |
| End period cash equivalent | -5.29%469.89M | -6.88%501.47M | -23.54%422.87M | -43.53%455.59M | 16.52%496.11M | 21.73%538.53M | -55.02%553.07M | 486.42%806.74M | 419.05%425.77M | 326.74%442.41M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
